FDAnews
www.fdanews.com/articles/199987-sientra-picks-ron-menezes-as-new-president-and-ceo

Sientra Picks Ron Menezes as New President and CEO

November 12, 2020

Santa Barbara, Calif.-based medical aesthetics product developer Sientra has named Ron Menezes as its new president and CEO.

Menezes brings nearly three decades of drug and aesthetics industry experience. He previously served as president and general manager of Almirall, a company focused on fighting skin diseases.

Sientra’s aesthetic products include the OPUS breast implant, the Allox2 breast-tissue expander and BioCorneum, a scar gel for plastic surgeons.

View today's stories